Oncogenic osteomalacia secondary to glomus tumor is extremely rare. Localization of causative tumors is critical as surgical resection can lead to a complete biochemical and clinical cure. We present a case of oncogenic osteomalacia treated with resection of glomus tumor. A 39-year-old woman with a history of chronic sinusitis presented with chronic body ache and muscle weakness. Biochemical evaluation revealed elevated alkaline phosphatase hypophosphatemia, increased urinary phosphate excretion, low calcitriol, and FGF23 was unsuppressed suggestive of oncogenic osteomalacia. Diagnostic studies showed increase uptake in multiple bones. Localization with MRI of paranasal sinuses revealed a sinonasal mass with concurrent uptake in the same area on the octreotide scan. Surgical resection of the sinonasal mass was consistent with the glomus tumor. The patient improved both clinically and biochemically postoperatively. Along with the case of oncogenic osteomalacia secondary to a glomus tumor, we have also discussed in detail the recent development in the diagnosis and management of oncogenic osteomalacia.

Learning points

  • Tumor-induced osteomalacia is a rare cause of osteomalacia caused by the secretion of FGF23 from mesenchymal tumors.
  • Mesenchymal tumors causing TIO are often difficult to localize and treat.
  • Resection of the tumor can result in complete resolution of biochemical and clinical manifestations in a very short span of time.
  • Glomus tumor can lead to tumor induced osteomalacia and should be surgically treated.

Document Type


Publication Date


Notes/Citation Information

Published in Endocrinology, Diabetes & Metabolism Case Reports, v. 2021, issue 1.

© 2021 The authors

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Digital Object Identifier (DOI)


Funding Information

Funding for this case report was provided by the Education Department of Pikeville Medical Center, Pikeville, KY.